The Axon Group, LTD

The Axon Group, LTD, a for-profit medical consulting firm based in Elkins Park, Pennsylvania, provides independent medical review services to the Social Security Administration as a prime contractor on blanket purchase agreements, competing in the open market with no set-aside designations across its entire footprint.

The Axon Group's federal work is entirely concentrated with a single customer — the Social Security Administration — which accounts for 57 of 59 awards (97% of award count) and $9.4 million of $10.2 million in combined potential value. The vendor operates exclusively under NAICS 621111 (Offices of Physicians) and PSC code 6850 (Medical — Medical/Psychiatric Consultation), conducting independent reviews of disability claim case files to assess claimant eligibility and impairment severity as part of SSA's disability determination process. Work is performed at the vendor's headquarters in Elkins Park, Pennsylvania, with geographic scope covering SSA Region 9 (California, Nevada, and Hawaii) and Region 3 (Mid-Atlantic).

The Axon Group holds two active single-award blanket purchase agreements with SSA. The Region 9 BPA, established August 23, 2023, carries a ceiling value of $2.73 million through December 31, 2027, with 14 prior task orders totaling $982 thousand in combined potential value — the largest concentration of work under a single vehicle. The Region 3 BPA, awarded August 1, 2021, with a $2.02 million ceiling expiring July 31, 2026, has generated 12 task orders valued at $1.2 million combined potential value. Representative call orders include a $378,288 firm fixed-price award issued July 1, 2026, under the Region 9 BPA for medical consultant services through June 30, 2027; a $126,096 call order issued December 30, 2025, for disability case file reviews through June 30, 2026; and a $65,158 Region 3 call order issued May 23, 2024, for 700 independent case reviews. Awards are structured as firm fixed-price call orders against the BPA IDVs, with individual call values ranging from under $200 to $189,144, specifying discrete case review volumes typically between 10 and 1,250 reviews per order.

Activity has been modest and uneven — two awards in 2022, six in 2023, and four each in 2024 and 2025 — with only one award recorded in 2026 to date. The vendor faces modest recompete exposure: two awards with ultimate completion dates in the next twenty-four months carry combined potential value of $511 thousand. The vendor holds no subcontract relationships in the source data and operates as a 100% prime contractor. Combined obligated dollars across all awards total $5.1 million, representing 51% utilization of the $10.2 million combined ceiling, indicating substantial remaining availability under the Region 9 and Region 3 IDVs.